Correction to: Inhibition of p53 and/or AKT as a new therapeutic approach specifically targeting ALT cancers

Yuanlong Ge; Shu Wu; Zepeng Zhang; Xiaocui Li; Feng Li; Siyu Yan; Haiying Liu; Junjiu Huang; Yong Zhao

doi:10.1007/s13238-019-0640-1

Correction to: Inhibition of p53 and/or AKT as a new therapeutic approach specifically targeting ALT cancers

Protein Cell. 2019 Dec;10(12):927-928. doi: 10.1007/s13238-019-0640-1.

Authors

Yuanlong Ge^#^{1

2}, Shu Wu^#^{1

2}, Zepeng Zhang^{1

2}, Xiaocui Li^{1

2}, Feng Li¹, Siyu Yan¹, Haiying Liu^{1

2}, Junjiu Huang¹, Yong Zhao^{3

4}

Affiliations

¹ MOE Key Laboratory of Gene Function and Regulation, State Key Laboratory of Biocontrol, School of Life Sciences, Sun Yat-sen University, Guangzhou, 510006, China.
² Collaborative Innovation Center of High Performance Computing, National University of Defense Technology, Changsha, 410073, China.
³ MOE Key Laboratory of Gene Function and Regulation, State Key Laboratory of Biocontrol, School of Life Sciences, Sun Yat-sen University, Guangzhou, 510006, China. [email protected].
⁴ Collaborative Innovation Center of High Performance Computing, National University of Defense Technology, Changsha, 410073, China. [email protected].

^# Contributed equally.

Abstract

In the original publication the labels in figure 4C and D are incorrectly published. The correct labels for figure 4C and D is provided in this correction.

Publication types

Published Erratum